Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Kidney Neoplasm|Lung Neoplasm|Sarcoma|Breast Neoplasm
Interventions: BIOLOGICAL: rh IL-12|BIOLOGICAL: rh IL-2
Sponsor: National Cancer Institute (NCI)